Dual drug-eluting stent

Journal of Controlled Release

Volumn 159, Issue 1, 2012, Pages 1-

  Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUERCETIN; RESVERATROL;

ANGIOPLASTY; BARE METAL STENT; CELL PROLIFERATION; CONTROLLED DRUG RELEASE; CORONARY STENT; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; EDITORIAL; HEART PROTECTION; IN-STENT RESTENOSIS; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RED WINE; STENT THROMBOSIS; THROMBOCYTE ACTIVATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CARDIOTONIC AGENTS; CORONARY RESTENOSIS; CORONARY THROMBOSIS; DELAYED-ACTION PREPARATIONS; DRUG-ELUTING STENTS; HUMANS; QUERCETIN; STILBENES;

EID: 84859510817     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.03.019     Document Type: Editorial

References (8)

1. C. Stettler, S. Wandel, S. Allemann, A. Kastrati, M.C. Morice, A. Schomig, M.E. Pfisterer, G.W. Stone, M.B. Leon, J.S. de Lezo, J.J. Goy, S.J. Park, M. Sabate, M.J. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M.T. Dirksen, P. Cervinka, A.S. Petronio, A.J. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, and P. Juni Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis Lancet 370 2007 937 948
2. M. Vorpahl, S.K. Yazdani, M. Nakano, E. Ladich, F.D. Kolodgie, A.V. Finn, and R. Virmani Pathobiology of stent thrombosis after drug-eluting stent implantation Curr. Pharm. Des. 16 2010 4064 4071
3. R. Vidavalur, H. Otani, P.K. Singal, and N. Maulik Significance of wine and resveratrol in cardiovascular disease: French paradox revisited Exp. Clin. Cardiol. 11 2006 217 225
4. L. Fremont Biological effects of resveratrol Life Sci. 66 2000 663 673
5. G. J, W. Cq, F. Hh, D. Hy, X. Xl, X. Ym, W. By, and H. Dj Effects of resveratrol on endothelial progenitor cells and their contributions to reendothelialization in intima-injured rats J. Cardiovasc. Pharmacol. 47 2006 711 721
6. M. Sanchez, F. Lodi, R. Vera, I.C. Villar, A. Cogolludo, R. Jimenez, L. Moreno, M. Romero, J. Tamargo, F. Perez-Vizcaino, and J. Duarte Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta J. Nutr. 137 2007 910 915
7. J.J. Kleinedler, J.D. Foley, E.A. Orchard, and T.R. Dugas Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization J. Control. Release 159 2012 27 33
8. J.J. Kleinedler, J.D. Foley, J.S. Alexander, S.C. Roerig, V.Y. Hebert, and T.R. Dugas Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices J. Biomed. Mater. Res. B Appl. Biomater. 99 2011 266 275